BLKB vs PAGS

The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no Altman Z-Score available to confirm safety from distress. Despite strong operating margins and recent earnings beats, the company is unprofitable overall (negative net margin and ROE), carries an extremely high debt/equity ratio of 9.93, and shows weak liquidity. Valuation multiples like a Price/Book of 24.60 appear stretched against poor profitability, while insider selling and declining revenue further undermine confidence. The stock trades below analyst targets but faces significant structural and financial headwinds.

PAGS presents a classic deep-value opportunity, anchored by a strong Piotroski F-Score of 7/9 and a Graham Number of $18.25, which is significantly above the current price of $10.02. While the company is facing a growth slowdown with negative Q/Q revenue and earnings trends, its financial health is robust with very low debt (D/E 0.18) and a highly sustainable 10.38% dividend yield. The extreme valuation discount (P/E 7.06, P/B 0.96) provides a substantial margin of safety that outweighs current technical bearishness. The synthesis of strong health and extreme undervaluation suggests a strong recovery potential.